Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

Inpatient treatment of children and adolescents with severe obesity in the Netherlands: a randomized clinical trial.

van der Baan-Slootweg O, Benninga MA, Beelen A, van der Palen J, Tamminga-Smeulders C, Tijssen JG, van Aalderen WM.

JAMA Pediatr. 2014 Sep;168(9):807-14. doi: 10.1001/jamapediatrics.2014.521.

PMID:
25022831
2.

Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.

Roe A, Hillman J, Butts S, Smith M, Rader D, Playford M, Mehta NN, Dokras A.

J Clin Endocrinol Metab. 2014 May;99(5):E841-7. doi: 10.1210/jc.2013-3918. Epub 2014 Feb 10.

PMID:
24512495
3.

Early atherogenesis and visceral fat in obese adolescents.

Slyper AH, Rosenberg H, Kabra A, Weiss MJ, Blech B, Gensler S, Matsumura M.

Int J Obes (Lond). 2014 Jul;38(7):954-8. doi: 10.1038/ijo.2014.11. Epub 2014 Jan 23.

PMID:
24451186
4.

The effectiveness of a comprehensive mind body weight loss intervention for overweight and obese adults: a pilot study.

Alert MD, Rastegar S, Foret M, Slipp L, Jacquart J, Macklin E, Baim M, Fricchione G, Benson H, Denninger J, Yeung A.

Complement Ther Med. 2013 Aug;21(4):286-93. doi: 10.1016/j.ctim.2013.05.005. Epub 2013 Jun 15.

PMID:
23876558
5.

Interventions for the metabolic dysfunction in polycystic ovary syndrome.

Bozdag G, Yildiz BO.

Steroids. 2013 Aug;78(8):777-81. doi: 10.1016/j.steroids.2013.04.008. Epub 2013 Apr 24. Review.

PMID:
23624033
6.

Recovery heart rate: an indicator of cardiovascular risk among middle school children.

Simhaee D, Corriveau N, Gurm R, Geiger Z, Kline-Rogers E, Goldberg C, Eagle KA, Jackson EA.

Pediatr Cardiol. 2013 Aug;34(6):1431-7. doi: 10.1007/s00246-013-0667-7. Epub 2013 Mar 13.

PMID:
23483242
7.

High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy.

Poli F, Pizza F, Mignot E, Ferri R, Pagotto U, Taheri S, Finotti E, Bernardi F, Pirazzoli P, Cicognani A, Balsamo A, Nobili L, Bruni O, Plazzi G.

Sleep. 2013 Feb 1;36(2):175-81. doi: 10.5665/sleep.2366.

8.

Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study.

Stringhini S, Tabak AG, Akbaraly TN, Sabia S, Shipley MJ, Marmot MG, Brunner EJ, Batty GD, Bovet P, Kivimäki M.

BMJ. 2012 Aug 21;345:e5452. doi: 10.1136/bmj.e5452.

9.

The change in one-hour postload plasma glucose levels, and an analysis of its related factors in abdominally obese Han Chinese men with normal glucose tolerance.

Qin CM, Wang R, Yin FZ, Liu B, Ma CM, Lu Q.

J Diabetes Complications. 2012 Nov-Dec;26(6):536-9. doi: 10.1016/j.jdiacomp.2012.05.022. Epub 2012 Jun 26.

PMID:
22739800
10.

ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK.

Kotseva K, Jennings CS, Turner EL, Mead A, Connolly S, Jones J, Bowker TJ, Wood DA; ASPIRE-2-PREVENT Study Group.

Heart. 2012 Jun;98(11):865-71. doi: 10.1136/heartjnl-2011-301603.

PMID:
22581735
11.

Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma).

Pandhi D, Gupta P, Singal A, Tondon A, Sharma S, Madhu SV.

Postgrad Med J. 2012 Apr;88(1038):198-204. doi: 10.1136/postgradmedj-2011-130443. Epub 2012 Feb 23.

PMID:
22362903
12.

Metabolic syndrome in a sample of the 6- to 16-year-old overweight or obese pediatric population: a comparison of two definitions.

Saffari F, Jalilolghadr S, Esmailzadehha N, Azinfar P.

Ther Clin Risk Manag. 2012;8:55-63. doi: 10.2147/TCRM.S26673. Epub 2012 Feb 2.

13.

A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers.

Albaugh VL, Singareddy R, Mauger D, Lynch CJ.

PLoS One. 2011;6(8):e22662. doi: 10.1371/journal.pone.0022662. Epub 2011 Aug 9.

14.

Metabolic risk varies according to waist circumference measurement site in overweight boys and girls.

Johnson ST, Kuk JL, Mackenzie KA, Huang TT, Rosychuk RJ, Ball GD.

J Pediatr. 2010 Feb;156(2):247-52.e1. doi: 10.1016/j.jpeds.2009.08.010. Epub 2009 Oct 27.

PMID:
19863969
15.

Relationships between cardiovascular risk profile, ultrasonographic measurement of intra-abdominal adipose tissue, and waist circumference in obese children.

Reinehr T, Wunsch R.

Clin Nutr. 2010 Feb;29(1):24-30. doi: 10.1016/j.clnu.2009.06.004. Epub 2009 Jul 2.

PMID:
19576664
16.

BMI and hyperinsulinemia in children.

Vogeser M, Schwandt P, Haas GM, Broedl UC, Lehrke M, Parhofer KG.

Clin Biochem. 2009 Sep;42(13-14):1427-30. doi: 10.1016/j.clinbiochem.2009.06.011. Epub 2009 Jun 25.

PMID:
19560447
17.

Is body mass index before middle age related to coronary heart disease risk in later life? Evidence from observational studies.

Owen CG, Whincup PH, Orfei L, Chou QA, Rudnicka AR, Wathern AK, Kaye SJ, Eriksson JG, Osmond C, Cook DG.

Int J Obes (Lond). 2009 Aug;33(8):866-77. doi: 10.1038/ijo.2009.102. Epub 2009 Jun 9. Review.

18.

Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006.

Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, Katzmarzyk PT.

Arch Pediatr Adolesc Med. 2009 Apr;163(4):371-7. doi: 10.1001/archpediatrics.2009.3.

PMID:
19349567
19.

Waist circumference predicts cardiovascular risk in young Australian children.

Watts K, Bell LM, Byrne SM, Jones TW, Davis EA.

J Paediatr Child Health. 2008 Dec;44(12):709-15. doi: 10.1111/j.1440-1754.2008.01411.x. Epub 2008 Nov 28.

PMID:
19077071
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk